<DOC>
	<DOCNO>NCT01420328</DOCNO>
	<brief_summary>This study focus use Vytorin study inflammatory marker subject normal cholesterol .</brief_summary>
	<brief_title>To Study Effect Vytorin Intracellular Lipid Inflammation Obese Subjects</brief_title>
	<detailed_description>Following first demonstration group macronutrient ( glucose , cream high fat high carbohydrate meal ) intake result increase ROS generation oxidative stress cellular molecular level , investigator show preliminary data cream intake induces comprehensive inflammation reflect increased intranuclear NFkB binding , decrease IkBα expression , increased expression IL-1β , IL-12 , TNFα pro-inflammatory mediator . While carry experiment , investigator ask whether cream intake associate uptake lipid peripheral blood mononuclear cell ( MNC ) . Indeed , significant increase intracellular lipid visualize intracellular lipid droplet . The increase intracellular lipid droplet associated increase intracellular superoxide generation ; expression CD68 , marker macrophage ; PECAM , adhesion molecule mediate trans- endothelial transfer leucocytes . The investigator also find lipid fraction increase cholesterol ester , triglyceride fatty acid . In view tantalize observation lipid droplet laden MNC appear monocyte , look like foam cell fact CD68 expression increase , possibility foam cell may form peripheral circulation monocyte lipid rich meal . This simple model foam cell formation also lend study effect various lipid lower drug . Our investigation first study novel paradigm . The investigator plan study effect cholesterol lower agent , Vytorin ( simvastatin ezetimibe ) , intracellular lipid MNC , expression CD68 PECAM , ROS generation inflammation obese subject . This investigation may provide additional mechanism action drug may reduce atherosclerosis .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<criteria>1 . Age 1865years . 2 . Obese BMI &gt; 30kg/m2 3 . LDL cholesterol &gt; 100 mg/dl 4 . Written inform consent sign dated 5 . Not vitamin/antioxidants 1 . On antilipid agent . 2 . Triglyceride &gt; 500mg/dl 3 . Myocardial infarction , angioplasty/stent placement coronary artery bypass surgery past 6 month 4 . Patient chronic use nonsteroidal antiinflammatory drug steroids 5 . Hepatic disease 6 . Renal impairment 7 . History drug alcohol abuse 8 . Participation concurrent clinical trial 9 . Use investigational agent therapeutic regimen within 30 day study . 10 . Smoker 11 . Pregnancy 12 . Premenopausal woman birth control pill hysterectomy tubal ligation 13 . Anemia hemoglobin &lt; 12 g/dl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>